x



Share this page.
bus

Toxicologists on Toxicology

In conjunction with the Society’s 50th anniversary in 2011, several SOT Past Presidents were interviewed about toxicology and their experiences as members of SOT.


Emerging Technologies Bring Excitement

James S. Bus, SOT Past President, 1996–1997

Dr. Bus is Director of External Technology, Toxicology and Environmental Research and Consulting at the Dow Chemical Company. He previously served as Associate Director of Toxicology and Director of Drug Metabolism at the Upjohn company, Senior Scientist at the Chemical Industry Institute of Toxicology and Assistant Professor of Toxicology, University of Cincinnati. His research interests include mechanism of oxidant toxicity, defense mechanisms to chemical toxicity, relationships of pharmacokinetics to expression of chemical toxicity, and general pesticide and industrial chemical toxicology.


Experiences & Opportunities with SOT

David L. Eaton, SOT Past President, 2001–2002

Dr. David Eaton, is Associate Vice Provost, Office of Research and a Professor, Environmental and Occupational Health Sciences at the University of Washington in Seattle, WA. His research interests include biochemical toxicology, aflatoxin carcinogenesis, glutathione-mediated biotransformations of toxic chemicals, genetic susceptibility to environmental carcinogens and gene-environment interactions. Dr. Eaton graduated with a Ph.D. from the University of Kansas Medical Center in Pharmacology and Toxicology.


Toxicology Is Part of the Solution

Jay I. Goodman, SOT Past President, 1999–2000

Toxicology Is Part of the Solution
Many people associate toxicology with poisons. In fact, toxicologists are the scientists who discover and describe how to reduce exposures and ways to use chemicals safely.

Dr. Jay Goodman is a Professor of Pharmacology and Toxicology at Michigan State University. Dr. Goodman’s research interests are in the area of epigenetics and the role(s) that change DNA methylation may play in carcinogenesis and other possible endpoints. He is testing the hypothesis that susceptibility to carcinogenesis is related inversely to the capacity to maintain normal patterns of DNA metylation. Dr. Goodman received his Ph.D. in Pharmacology from the University of Michigan.


SOT Offers Students Adrenaline

Kendall B. Wallace, SOT Past President, 2005–2006

Dr. Kendall Wallace is the Director of the University of Minnesota Medical School’s Toxicology Graduate Program. He is a Fellow at the Academy of Toxicological Sciences and is a Diplomate of the American Board of Toxicology. Dr. Wallace received his Ph.D. from Michigan State University and was Postdoctoral Fellow at the University of Iowa.


Students Love to Solve the Mystery

Kendall B. Wallace, SOT Past President, 2005–2006

Dr. Kendall Wallace is the Director of the University of Minnesota Medical School’s Toxicology Graduate Program. He is a Fellow at the Academy of Toxicological Sciences and is a Diplomate of the American Board of Toxicology. Dr. Wallace received his Ph.D. from Michigan State University and was Postdoctoral Fellow at the University of Iowa.


Toxicologists Provide the Tools to Help Us Live in a Safe Environment

Kendall B. Wallace, SOT Past President, 2005–2006

Dr. Kendall Wallace is the Director of the University of Minnesota Medical School’s Toxicology Graduate Program. He is a Fellow at the Academy of Toxicological Sciences and is a Diplomate of the American Board of Toxicology. Dr. Wallace received his Ph.D. from Michigan State University and was Postdoctoral Fellow at the University of Iowa.